Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C40H63N9O8S |
Molar mass | 830.06 g·mol−1 |
3D model ( JSmol) | |
| |
|
Barusiban ( INN) (code name FE-200440) is a non- peptide drug which is among the most potent and selective oxytocin receptor antagonists known. [1] [2] It was trialed by Ferring Pharmaceuticals as a treatment of preterm labor but failed to demonstrate effectiveness and was not pursued any further. [1] [3]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C40H63N9O8S |
Molar mass | 830.06 g·mol−1 |
3D model ( JSmol) | |
| |
|
Barusiban ( INN) (code name FE-200440) is a non- peptide drug which is among the most potent and selective oxytocin receptor antagonists known. [1] [2] It was trialed by Ferring Pharmaceuticals as a treatment of preterm labor but failed to demonstrate effectiveness and was not pursued any further. [1] [3]